Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP938498.RAjl6iiN6WAyp98RmO0UMEnclNKx-0a29qTXcHq9Ufn-k130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP938498.RAjl6iiN6WAyp98RmO0UMEnclNKx-0a29qTXcHq9Ufn-k130_assertion type Assertion NP938498.RAjl6iiN6WAyp98RmO0UMEnclNKx-0a29qTXcHq9Ufn-k130_head.
- NP938498.RAjl6iiN6WAyp98RmO0UMEnclNKx-0a29qTXcHq9Ufn-k130_assertion description "[Excessive activation of the ?-adrenergic, angiotensin II (Ang II) and aldosterone signaling pathways promotes mortality after myocardial infarction, and antagonists targeting these pathways are core therapies for treating this condition.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP938498.RAjl6iiN6WAyp98RmO0UMEnclNKx-0a29qTXcHq9Ufn-k130_provenance.
- NP938498.RAjl6iiN6WAyp98RmO0UMEnclNKx-0a29qTXcHq9Ufn-k130_assertion evidence source_evidence_literature NP938498.RAjl6iiN6WAyp98RmO0UMEnclNKx-0a29qTXcHq9Ufn-k130_provenance.
- NP938498.RAjl6iiN6WAyp98RmO0UMEnclNKx-0a29qTXcHq9Ufn-k130_assertion SIO_000772 22081025 NP938498.RAjl6iiN6WAyp98RmO0UMEnclNKx-0a29qTXcHq9Ufn-k130_provenance.
- NP938498.RAjl6iiN6WAyp98RmO0UMEnclNKx-0a29qTXcHq9Ufn-k130_assertion wasDerivedFrom befree-2016 NP938498.RAjl6iiN6WAyp98RmO0UMEnclNKx-0a29qTXcHq9Ufn-k130_provenance.
- NP938498.RAjl6iiN6WAyp98RmO0UMEnclNKx-0a29qTXcHq9Ufn-k130_assertion wasGeneratedBy ECO_0000203 NP938498.RAjl6iiN6WAyp98RmO0UMEnclNKx-0a29qTXcHq9Ufn-k130_provenance.